Paul Campanelli, EVP, President - Generics at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), sold 24,885 shares at $25.04 ($623K) on 2010-03-02, disclosed to the SEC on 2010-03-03.
Seasonal sale ($623k) by EVP, President - Generics — this insider has traded PRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 12,485 | $312K | 50.1% |
| 2 | $25.01 | 600 | $15K | 2.4% |
| 3 | $25.02 | 200 | $5K | 0.8% |
| 4 | $25.03 | 100 | $3K | 0.4% |
| 5 | $25.04 | 300 | $8K | 1.2% |
| 6 | $25.05 | 700 |
| $18K |
| 2.8% |
| 7 | $25.06 | 100 | $3K | 0.4% |
| 8 | $25.06 | 3,600 | $90K | 14.5% |
| 9 | $25.07 | 500 | $13K | 2.0% |
| 10 | $25.08 | 100 | $3K | 0.4% |
| 11 | $25.08 | 600 | $15K | 2.4% |
| 12 | $25.09 | 200 | $5K | 0.8% |
| 13 | $25.10 | 200 | $5K | 0.8% |
| 14 | $25.11 | 4,800 | $121K | 19.3% |
| 15 | $25.12 | 300 | $8K | 1.2% |
| 16 | $25.13 | 100 | $3K | 0.4% |
| Total | $25.04 avg | 24,885 | $623K | 100% |
| Filing → |
| ENDP | BUY | 2016-05-11 | $202K | — | Filing → |
| ENDP | BUY | 2015-11-12 | $117K | — | Filing → |
| PRX | SELL | 2011-03-09 | $1.5M | — | Filing → |